tiprankstipranks
Trending News
More News >
Global Health Limited (IN:MEDANTA)
:MEDANTA
India Market

Global Health Limited (MEDANTA) Ratios

Compare
0 Followers

Global Health Limited Ratios

IN:MEDANTA's free cash flow for Q4 2025 was ₹0.55. For the 2025 fiscal year, IN:MEDANTA's free cash flow was decreased by ₹ and operating cash flow was ₹0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.34 2.44 2.76 1.94 1.24
Quick Ratio
1.23 2.33 2.65 1.81 1.14
Cash Ratio
0.41 0.69 1.34 0.28 0.17
Solvency Ratio
0.11 0.47 0.28 0.21 0.12
Operating Cash Flow Ratio
0.49 0.99 1.13 0.74 0.60
Short-Term Operating Cash Flow Coverage
10.66 4.50 6.13 4.43 3.61
Net Current Asset Value
₹ -1.08B₹ 1.10B₹ -1.08B₹ -7.18B₹ -8.10B
Leverage Ratios
Debt-to-Assets Ratio
0.35 0.19 0.27 0.35 0.35
Debt-to-Equity Ratio
0.69 0.28 0.46 0.69 0.67
Debt-to-Capital Ratio
0.41 0.22 0.32 0.41 0.40
Long-Term Debt-to-Capital Ratio
0.31 0.09 0.23 0.32 0.29
Financial Leverage Ratio
1.98 1.48 1.70 1.95 1.95
Debt Service Coverage Ratio
3.08 3.47 3.03 2.65 1.68
Interest Coverage Ratio
2.47 16.14 6.86 4.31 1.38
Debt to Market Cap
0.06 0.01 0.06 0.08 0.06
Interest Debt Per Share
39.16 32.55 46.29 47.11 39.72
Net Debt to EBITDA
0.52 0.43 0.52 2.06 3.78
Profitability Margins
Gross Profit Margin
78.09%52.42%76.79%74.82%75.64%
EBIT Margin
7.75%21.36%19.57%16.70%6.96%
EBITDA Margin
15.89%26.62%25.17%22.23%15.96%
Operating Profit Margin
8.50%35.75%19.85%15.77%6.48%
Pretax Profit Margin
4.31%19.15%16.68%13.01%2.27%
Net Profit Margin
2.45%14.60%12.10%9.10%2.01%
Continuous Operations Profit Margin
2.45%14.60%12.10%9.10%2.01%
Net Income Per EBT
56.88%76.25%72.58%69.93%88.73%
EBT Per EBIT
50.67%53.55%84.01%82.52%35.02%
Return on Assets (ROA)
7.92%11.11%7.92%6.24%1.07%
Return on Equity (ROE)
13.43%16.46%13.43%12.14%2.08%
Return on Capital Employed (ROCE)
15.09%31.77%15.09%12.47%4.05%
Return on Invested Capital (ROIC)
10.54%23.14%10.54%8.40%3.44%
Return on Tangible Assets
7.93%11.12%7.93%6.25%1.07%
Earnings Yield
2.39%1.34%2.39%1.88%0.28%
Efficiency Ratios
Receivables Turnover
8.08 13.87 0.00 9.76 8.64
Payables Turnover
81.28 8.34 3.21 4.04 2.65
Inventory Turnover
8.43 23.31 10.36 10.17 8.77
Fixed Asset Turnover
0.71 1.25 1.14 0.98 0.69
Asset Turnover
0.56 0.76 0.65 0.69 0.53
Working Capital Turnover Ratio
9.45 3.45 3.85 8.80 13.10
Cash Conversion Cycle
-78.41 -1.77 -78.41 -17.02 -53.90
Days of Sales Outstanding
0.00 26.31 0.00 37.40 42.22
Days of Inventory Outstanding
35.24 15.66 35.24 35.89 41.63
Days of Payables Outstanding
113.65 43.75 113.65 90.31 137.76
Operating Cycle
35.24 41.97 35.24 73.29 83.86
Cash Flow Ratios
Operating Cash Flow Per Share
7.00 22.79 24.86 12.34 9.62
Free Cash Flow Per Share
-0.53 12.42 15.76 1.46 3.82
CapEx Per Share
7.52 10.37 9.10 10.88 5.80
Free Cash Flow to Operating Cash Flow
-0.08 0.54 0.63 0.12 0.40
Dividend Paid and CapEx Coverage Ratio
0.93 2.20 2.73 1.13 1.66
Capital Expenditure Coverage Ratio
0.93 2.20 2.73 1.13 1.66
Operating Cash Flow Coverage Ratio
0.19 0.76 0.57 0.28 0.26
Operating Cash Flow to Sales Ratio
0.12 0.19 0.24 0.14 0.17
Free Cash Flow Yield
2.99%0.93%2.99%0.35%0.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
285.31 74.78 41.89 53.23 361.47
Price-to-Sales (P/S) Ratio
6.99 10.92 5.07 4.84 7.28
Price-to-Book (P/B) Ratio
7.68 12.31 5.63 6.46 7.53
Price-to-Free Cash Flow (P/FCF) Ratio
-785.18 107.22 33.43 283.89 108.42
Price-to-Operating Cash Flow Ratio
59.20 58.42 21.19 33.55 43.07
Price-to-Earnings Growth (PEG) Ratio
-9.63 1.80 0.68 0.09 -17.47
Price-to-Fair Value
7.68 12.31 5.63 6.46 7.53
Enterprise Value Multiple
47.33 41.45 20.67 23.85 49.38
Enterprise Value
140.14B 361.36B 140.14B 114.33B 112.74B
EV to EBITDA
20.67 41.45 20.67 23.85 49.38
EV to Sales
5.20 11.03 5.20 5.30 7.88
EV to Free Cash Flow
34.30 108.35 34.30 310.78 117.40
EV to Operating Cash Flow
21.74 59.04 21.74 36.73 46.63
Tangible Book Value Per Share
53.59 107.97 93.48 63.84 54.70
Shareholders’ Equity Per Share
53.93 108.17 93.68 64.09 54.98
Tax and Other Ratios
Effective Tax Rate
0.43 0.24 0.27 0.30 0.11
Revenue Per Share
59.24 121.93 103.94 85.50 56.90
Net Income Per Share
1.45 17.80 12.58 7.78 1.15
Tax Burden
0.73 0.76 0.73 0.70 0.89
Interest Burden
0.85 0.90 0.85 0.78 0.33
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.12 0.15 0.12 0.02 0.02
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.43 1.28 1.43 1.11 7.45
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis